Yk Hamied

Sharing information with company's shareholders in the drug firm's annual report for 2019-20, Hamied said the company is at the forefront in the fight against COVID-19.

YK Hamied to increase stake in Cipla to over 20%

Hamied (80), who is the Non-Executive Chairman of the company, will acquire 5.22 percent additional stake from his wife Farida Hamied thereby taking his total holding in the drug firm to 20.76 percent from earlier stake of 15.54 percent, Cipla said in a regulatory filing.

Cipla spends Rs 274cr to set up API facilities

Pharma major Cipla has spent Rs 274 crore towards setting up an Active Pharmaceutical Ingredient (API) R&D facility at Patalganga in Maharashtra, and commenced commercial production of anticancer APIs at Bommasandra, Bengalore and anti-ulcerant APIs at Kurkumbh in Maharashtra.

Aim to see turnover of USD 5 bn by 2020: Cipla Chairman

Cipla reported a better-than-expected second quarter earnings. In an interview to CNBC-TV18, Chairman of the company YK Hamied said that the pharma major is expecting to achieve a turnover of USD 5 billion by the year 2020.

Cipla launches anti-malarial drug in India

In an interview to CNBC-TV18, YK Hamied, chairman and managing director of Cipla says, the company is launching an anti-malarial drug in India. "Today, being the World Malaria day, we are launching a new combination drug along with our partners who are based in Geneva called DNDI," he asserts.

Cipla aims for 8-10% revenues this yr; Eyes overseas growth

YK Hamied, the CMD of Cipla is optimistic the pharma major will post a topline growth of 8-10% this fiscal.In an interview to CNBC-TV18, he says he is looking at the company's bottomline increasing by Rs 1,000 crore in FY13.

Cipla disappoints; says Indore SEZ to add 10% to FY12 sales

Rationalising the company's dismal performance during the quarter, chairman and managing director YK Hamied said that the special economic zone (SEZ) at Indore and higher material costs led to lower profitability. "Also, selling anti AIDS and malaria drugs to Africa at humanitarian prices too had an impact."